Topical anti-aging peptides fall into four categories — signal, enzyme-inhibitor, neurotransmitter-inhibitor, and carrier — each with varying levels of clinical evidence for treating skin aging.
4 functional categories of cosmetic peptidesSignal peptides boost collagen, enzyme-inhibitors prevent protein breakdown, neurotransmitter-inhibitors relax muscles, and carrier peptides deliver minerals — each with different evidence levels.
What the researchers found
Topical peptides used in anti-aging skincare fall into four functional categories: signal peptides (which stimulate collagen and other protein production), enzyme-inhibitor peptides (which block enzymes that break down skin proteins), neurotransmitter-inhibitor peptides (which relax facial muscles to reduce wrinkles, similar to botox), and carrier peptides (which deliver trace elements like copper to skin cells). The review assessed controlled ex vivo and in vivo studies for these categories, evaluating the evidence base for their efficacy in treating signs of skin aging.
Why it matters
The cosmetic peptide market is enormous, but the gap between marketing claims and scientific evidence is wide. This review provides one of the first comprehensive, evidence-based classifications of topical peptides used in anti-aging products, helping consumers and clinicians understand which peptide categories have real support and which are largely unproven.
How the study worked
Comprehensive literature review of controlled ex vivo (tissue) and in vivo (human) efficacy studies evaluating any topical peptide or protein used to treat signs and symptoms of skin aging. Studies were categorized by peptide mechanism: signal, enzyme-inhibitor, neurotransmitter-inhibitor, and carrier.
Who was studied
Review of controlled studies in human subjects and ex vivo skin tissue
What this study cannot tell us
The abstract notes that aging is not preventable, and topical approaches can only alter the process rather than reverse it. As a 2009 review, it does not capture more recent research on newer peptide formulations. The review is limited to what was available in the published literature at the time, and many cosmetic peptide claims still lack rigorous clinical trials.
How to read the evidence
This is a review article that evaluates existing controlled studies. While it does not generate new data, it provides a systematic assessment of the evidence for topical anti-aging peptides, drawing from both ex vivo and in vivo human studies.
When this study was published
Published in 2009, this review is over 15 years old. While the four-category classification system remains the standard framework, many newer peptides and formulation technologies have emerged since publication. Some findings may not reflect current best practices.
The bigger picture
This review helped establish the scientific framework that the cosmetic peptide industry still uses today. By categorizing peptides by mechanism rather than brand name, it gave researchers and consumers a way to evaluate anti-aging claims. The four-category system — signal, enzyme-inhibitor, neurotransmitter-inhibitor, and carrier peptides — became a standard reference in cosmetic dermatology.
Questions still open
- Which of the four peptide categories has the strongest clinical evidence for visible anti-aging results?
- Can topical peptides actually penetrate the skin barrier deeply enough to reach their targets?
- How do these cosmetic peptide categories compare in efficacy to retinoids and other proven anti-aging ingredients?
Common questions
What are the four types of anti-aging peptides in skincare?
Do anti-aging peptide creams actually work?
Read the original research
Role of topical peptides in preventing or treating aged skin.
International journal of cosmetic science, 31(5), 327-45
Citation
Gorouhi, F; Maibach, H I. (2009). Role of topical peptides in preventing or treating aged skin.. International journal of cosmetic science, 31(5), 327-45. https://doi.org/10.1111/j.1468-2494.2009.00490.x